Throop Gerald C 4
4 · Ceridian HCM Holding Inc. · Filed May 12, 2022
Insider Transaction Report
Form 4
Throop Gerald C
Director
Transactions
- Award
Option (right to buy)
2022-05-11+17,555→ 17,555 totalExercise: $50.23Exp: 2032-05-11→ Common Stock (17,555 underlying)
Holdings
- 4,643
Option (right to buy)
Exercise: $74.20Exp: 2030-08-21→ Common Stock (4,643 underlying) - 10,069
Option (right to buy)
Exercise: $87.40Exp: 2031-05-07→ Common Stock (10,069 underlying) - 23,185
Exchangeable Shares
→ Common Stock (23,185 underlying) - 11,916
Option (right to buy)
Exercise: $65.26Exp: 2030-05-08→ Common Stock (11,916 underlying) - 14,638
Common Stock
Footnotes (4)
- [F1]Includes (i) 7,955 shares issuable at the election of the recipient pursuant to vested Restricted Stock Units (RSU), granted on April 25, 2018, (ii) 3,988 shares issuable at the election of the recipient pursuant to vested RSUs, granted on May 15, 2019, and (iii) of the 2,695 RSUs granted on August 21, 2020, 898 shares are issuable at the election of the recipient pursuant to vested RSUs, and 898 and 899 RSUs vest and become issuable at the election of the recipient on August 21, 2022 and August 21, 2023, respectively.
- [F2]Represents exchangeable shares of Ceridian AcquisitionCo ULC, a wholly owned subsidiary of the Issuer, that are exchangeable at the option of the holder for shares of common stock of the Issuer. Each exchangeable share is convertible into one share of common stock of the Issuer, subject to adjustment. The exchangeable shares are currently exercisable and have no expiration date.
- [F3]Fully vested and exercisable.
- [F4]These options, granted on May 11, 2022, vest and become exercisable as to 25% of the option on the day of each three-month period commencing on the date of grant.